AtriCure, Inc. (ATRC)  has launched the cryoSPHERE MAX cryoablation probe, which enhances Cryo Nerve Block (cryoNB) therapy by reducing freeze times by 50% compared to previous models and over 30% when compared to the cryoSPHERE+ probe.cryoNB therapy, using AtriCure’s cryoICE technology, is a non-pharmacological method to freeze targeted intercostal nerves, providing temporary pain relief along peripheral nerve pathways.The cryoSPHERE MAX device, part of AtriCure’s cryoNB therapy, cuts ablation time by 50% ...